NCM
IBIO icon

Noesis Capital Mangement’s iBio IBIO Stock Holding History

Noesis Capital Mangement’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Buy
405,000
+93,500
+30% +$167K 0.09% 66
2026
Q1 		$592K Buy
311,500
+87,300
+39% +$203K 0.09% 67
2025
Q4 		$433K Buy
+224,200
New +$306K 0.06% 80

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Noesis Capital Mangement's IBIO Position: Q2 2026 in Review

Noesis Capital Mangement increased its iBio (IBIO) stake by 30% in Q2 2026, buying an estimated $167K and bringing the position to 405,000 shares worth $709K. The position accounts for 0.09% of the portfolio, ranked #66.

Noesis Capital Mangement first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Noesis Capital Mangement held 405,000 shares of iBio worth $709K as of Q2 2026.
  • Noesis Capital Mangement bought 93,500 iBio shares in Q2 2026, an estimated $167K.
  • iBio made up 0.09% of Noesis Capital Mangement's portfolio in Q2 2026, its #66 holding.
  • Noesis Capital Mangement first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Noesis Capital Mangement's 13F filing for Q2 2026, filed 4 Aug 2026.